As-Needed Use of Short-Acting b2-Agonists Alone Versus As-Needed Use of Short-acting b2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients With Mild Intermittent (Step 1) Asthma: A Cost- Effectiveness Analysis

Brit Trogen, Scott Sicherer

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)S52-S53
JournalPediatrics
Volume152
DOIs
StatePublished - 10 Dec 2023

Cite this